Cancer statistics, trends, and multiple primary cancer analyses from the surveillance, epidemiology, and end results (SEER) program

Oncologist

Volumn 12, Issue 1, 2007, Pages 20-37

  Hayat, Matthew J ^a   Howlader, Nadia ^a   Reichman, Marsha E ^a   Edwards, Brenda K ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cancer statistics; Incidence; Lifetime risk; Multiple primaries; SEER; Survival

Indexed keywords

AGING; ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER RISK; CANCER STATISTICS; CANCER SURVIVAL; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SEX DIFFERENCE; UNITED STATES;

FEMALE; HUMANS; INCIDENCE; MALE; NEOPLASMS; PREVALENCE; RISK FACTORS; SEER PROGRAM; UNITED STATES;

EID: 33846436108     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.12-1-20     Document Type: Article

References (37)

1. Hankey BF, Ries LA, Edwards BK. The surveillance, epidemiology, and end results program: A national resource. Cancer Epidemiol Biomarkers Prev 1999;1117-1121.
2. Fritz A, Percy C, Jack A et al. International Classification of Diseases for Oncology. 3rd ed. Geneva: World Health Organization, 2000.
3. Greene FL, Page DL, Fleming ID et al., eds. AJCC Cancer Staging Manual. 6th ed. New York: Springer, 2002.
4. Centers for Disease Control and Prevention/National Center for Health Statistics. Available at http://www.cdc.gov/nchs/Default.htm. Accessed November 15, 2006.
5. Ries LA, Harkins D, Krapcho M et al. SEER Cancer Statistics Review, 1975-2003. Bethesda, MD: National Cancer Institute, 2006.
6. U.S. Census Bureau. National population projections I. Summary files. Available at http://www.census.gov/population/www/projections/natsum-T3.html. Accessed December 11, 2006.
7. Clegg LX, Feuer EJ, Midthune DN et al. Impact of reporting delay and reporting error on cancer incidence rates and trends. J Natl Cancer Inst 2002;94:1537-1545.
8. Kim HJ, Fay MP, Feuer EJ et al. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2001;19:335-351.
9. Fay MP, Pfeiffer R, Cronin KA et al. Age-conditional probabilities of developing cancer. Stat Med 2003;22:1837-1848.
10. Fay MP. Estimating age conditional probability of developing disease from surveillance data. Popul Health Metr 2004;2:6.
11. Feuer EJ, Wun LM, Boring CC et al. The lifetime risk of developing breast cancer. J Natl Cancer Inst 1993;892-897.
12. DevCan: Probability of Developing or Dying of Cancer Software, version 6.0.1. 2005.
13. Ederer F, Axtell LM, Cutler SJ. The relative survival rate: A statistical methodology. J Natl Cancer Inst Monogr 1961;101-121.
14. Johnson C, ed. SEER Program Coding and Staging Manual 2004. 4th ed. Bethesda, MD: National Cancer Institute, 2004. NIH publication no. 04-5581.
15. Armitage P, Berry G, Matthews JNS, eds. Statistical Methods in Medical Research. 4th ed. Oxford: Blackwell Scientific Publications, 1987.
16. U.S. Census Bureau. Interim projections of the U.S. population by age, sex, race, and Hispanic origin: Summary methodology and assumptions. Available at http://www.census.gov/ipc/www/usinterimproj/idbsummeth.html. Accessed December 11, 2006.
17. U.S. Census Bureau. National population projections. Available at http://www.census.gov/population/www/projections/natproj.html. Accessed December 11, 2006.
18. American Cancer Society. Cancer Facts and Figures 2006. Atlanta: American Cancer Society, 2006.
19. Kramárová E, Stiller CA, Ferlay J et al. International Classification of Childhood Cancer 1996. IARC Technical Report No. 29. Lyon: International Agency for Research of Cancer, 1996.
20. Howe HL, Wu XC, Ries LAG et al. Annual report to the nation on the status of cancer, 1975-2003, featuring cancer among U.S. Hispanic/Latino populations. Cancer 2006;107.
21. Ron E. Thyroid cancer. In: Schottenfeld D, Fraumeni Jr JF, eds. Cancer Epidemiology and Prevention. 2nd ed. Oxford, U.K.: Oxford University Press, 1996:1000-1021.
22. Rossouw J, Anderson G, Prentice R et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-333.
23. Howe HL, Wu X, Ries LAG et al. Annual report to the nation on the status of cancer, 1975-2003, featuring cancer among U.S. Hispanic/Latino populations. Cancer 2006;107:1711-1742.
24. Berry DA, Cronin KA, Plevritis SK et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 2005;353:1784-1792.
25. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 2006;295:2164-2167.
26. Fu JB, Kau TY, Severson RK et al. Lung cancer in women: Analysis of the national Surveillance, Epidemiology, and End Results database. Chest 2005;127:768-777.
27. Devesa SS, Bray F, Vizcaino AP et al. International lung cancer trends by histologic type: Male:female differences diminishing and adenocarcinoma rates rising. Int J Cancer 2005;117:294-299.
28. National Cancer Institute. National lung screening trial. Available at http://www.cancer.gov/nlst. Accessed November 15, 2006.
29. Edwards BK, Brown ML, Wingo PA et al. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 2005;97:1407-1427.
30. National Cancer Institute. Cancer survivor research. Available at http://cancercontrol.cancer.gov/ocs. Accessed November 6, 2006.
31. Curtis RE, Freedman DM, Ron E et al., eds. New Malignancies Among Cancer Survivors: SEER Cancer Registries, 1973-2000. Bethesda, MD: National Cancer Institute, 2006.
32. Fraumeni JF Jr., Curtis RE, Edwards BK et al. Introduction. In: Curtis RE, Freedman DM, Ron E et al., eds. New Malignancies Among Cancer Survivors: SEER Cancer Registries, 1973-2000. Bethesda, MD: National Cancer Institute, 2006.
33. Habuchi T. Origin of multifocal carcinomas of the bladder and upper urinary tract: Molecular analysis and clinical implications. Intl J Urol 2005;12:709-716.
34. Tabor M, Brakenhoff RH, Ruijter-Schippers HJ et al. Multiple head and neck tumors frequently originate from a single preneoplastic lesion. Am J Pathol 2002;161:1051-1060.
35. Canchola AJ, Horn-Ross PL, Purdie DM. Risk of secondary primary malignancies with papillary thyroid cancer. Am J Epidemiol 2006;163:521-527.
36. Hewitt M, Greenfield S, Stovall E, eds. From Cancer Patient to Cancer Survivor: Lost in Transition. Washington: The National Academies Press, 2006.
37. National Cancer Institute. President's Cancer Panel. Assessing progress, advancing change. 2005-2006 Annual report. Available at http://deainfo.nci.nih. gov/advisory/pcp/pcp06rpt/pcp06rpt.pdf2006. Accessed June 1, 2006.